WEDNESDAY, May 4, 2022 (HealthDay News) – For patients surviving acute myocardial infarction (AMI), 10-year mortality and recurrence rates have declined over the past decade, according to a survey published online May 4. Clothing Cardiology.
Eun Wang, a PhD from Yale New Haven Hospital in Connecticut, and colleagues examined the 10-year universal mortality rate and recurrent hospitalization for AMI by a demographic subgroup among Medicare fee-for-service beneficiaries who have survived AMI since 1995. Until 2019. Data for 3,982,266 AMI survivors are included.
The researchers found that the 10-year mortality rate was 72.7 percent and the recurrent AMI rate was 27.1 percent. For mortality and recurrence, the consistent annual declines were 1.5 and 2.7 percent, respectively. In the subgroup analysis, mortality and recurrence risk ratios were 1.13 and 1.07 for males and females, respectively; 1.05 and 1.08 for black and white patients, respectively; 0.96 and 1.00 for patients of other races and whites, respectively; And 1.24 and 1.21 for dual and non-dual Medicare-Medicaid eligible patients, respectively. Compared to hospital admissions from 1995 to 1997, hospital admissions from 2007 to 2009, the 10-year mortality rate and 10-year recurrence risk were significantly lower (adjusted risk ratios, 0.86 and 0.77, respectively). Compared to non-recurrent patients, recurrent AMI patients had an increase in mortality within 10 years of initial AMI (80.6 vs. 72.4 percent).
“Differences between results and temporal trends have been observed across demographic subgroups,” the author wrote. “National efforts to reduce inequality in the long-term outcome should make healthcare a priority in the United States for decades to come.”
One author reveals the financial relationship with the pharmaceutical, healthcare and legal industries.
Abstract / Full Text (may require subscription or payment)